Search

everythinglearnresearchcommunity

for

Search:↓

Selecting Angus cattle for earlier puberty lowers prolactin levels but doesn't affect hair growth.

Long-term steroid abuse in athletes causes serious health risks, outweighing any benefits.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Pharmacists play a crucial role in improving patient outcomes through personalized care and staying updated with scientific advancements.

Early investigation and a team approach are crucial for managing primary amenorrhea effectively.

The genus Sophora has compounds with potential health benefits and could lead to new drugs, but more research is needed to understand their effects and safety.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Cocaine impairs male sexual behavior and alters testosterone metabolism in the brain.

Forensic hair analysis for drugs is now more reliable and accurate.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

Frontal fibrosing alopecia can be managed with personalized combination therapies, but no cure exists yet.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Menopause often leads to lower sexual desire and discomfort during sex, but treatment should be personalized and only if it bothers the woman.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Soymetide-4 from soy can prevent hair loss caused by a cancer drug in rats.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.